Chemicals mergers and acquisitions will take priority this year, as expected by DHS Holdings. While the chemicals industry is experienced in navigating headwinds, the global pandemic brought with it some unique challenges that caused many chemicals companies to focus inward, putting M&A transactions on pause. Despite the pause in M&A caused by COVID-19, 2020 still finished with solid M&A activity in the industry, with over 500 transactions, 8 of which were in excess of $1 billion. How are chemical executives re-prioritizing in the face of this global pandemic heading into 2021?
Comments